Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025

Core Insights - Invivyd, Inc. is set to present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025, at 1:20 PM ET [1] - The company focuses on developing protection against serious viral infectious diseases, starting with SARS-CoV-2, utilizing a proprietary integrated technology platform [2] Company Overview - Invivyd, Inc. is a biopharmaceutical company listed on Nasdaq under the ticker IVVD [2] - The company has received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody in its pipeline [2] - Invivyd's technology platform is designed to assess, monitor, develop, and adapt to create best-in-class antibodies [2]